Branding the acquisition as the world's premier biopharmaceutical company, Pfizer and Wyeth launched a Web site, which includes podcasts and vodcasts of the companies' CEOs talking about the acquisition as well as information for patients and consumers, investors, and media.
But, the announcement also came with the news that Pfizer would cut its work force by 10% and reduce the number of manufacturing sites while it prepares to lose half of its pharmaceutical revenue stream by 2015, when the patents for Lipitor, Viagra, and other medications expires.
Here's a link to a video and two podcasts that features Pfizer's Ray Kerins and Wyeth's Gwen Fisher talking about social media, CSR, and drug safety communications at a PRWeek healthcare panel that was held in Philadelphia in November.
Have you registered with us yet?
Register now to enjoy more articles and free email bulletinsRegister
Already registered?Sign in
Join a growing community of PRWeek comms professionals today
- Read more articles each month
- Sign up for free specialised news bulletins